Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-23-000089

SVP Corporate Strategy-Develop sold 2,303 shares at $115.00 ($264,845)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dolan Matthew Vincent SVP Corporate Strategy-Develop 2023-03-16 Sale −2,303 $115.00 $264,845 33,569 D: show line 1 in the form
Open-market sales · 2,303 sh · avg $115.00 · $264,845
Loading xslF345X03/edgardoc.xml…